Department of Cardiology, University of Toronto, 27 King’s College Cir, Toronto, ON M5S 1A1, Canada
Mini Review
Advancements in Nanotechnology for Drug Delivery in Coronary Artery Disease: Enhancing Efficacy and Minimizing Side Effects
Author(s): Annie Marques*
Coronary artery disease remains a leading cause of mortality and morbidity worldwide. The conventional treatment approaches often face limitations
such as low drug bioavailability, off-target effects and inadequate therapeutic outcomes. Nanotechnology has emerged as a promising solution
to address these challenges by enabling targeted drug delivery to the affected site, thereby enhancing therapeutic efficacy while minimizing
systemic side effects. This article reviews recent advancements in nanotechnology-based drug delivery systems for CAD treatment, highlighting
the strategies to improve drug selectivity, stability and controlled release. Furthermore, the potential benefits and challenges of these novel
approaches are discussed, along with their potential to revolutionize the management of CAD... Read More»
DOI:
10.37421/2684-6020.2023.7.176
Journal of Coronary Heart Diseases received 15 citations as per Google Scholar report